What is Ardelyx Inc (ARDX) stock price today?

Ardelyx Inc (ARDX) currently trades at $6.01 per share. The stock has a market capitalization of $1.47B and a P/E ratio of —x.

Is ARDX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Ardelyx Inc has a Smart Value Score of 27/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is -1.04.

What is Ardelyx Inc's revenue and earnings?

Ardelyx Inc has trailing twelve-month (TTM) revenue of $407.32M with profit margins of -15.10%. Earnings per share (EPS) is $-0.26.

Is Ardelyx Inc financially healthy?

Ardelyx Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of -1.04 places it in the distress.

ARDX

Ardelyx Inc

NASDAQ: ARDX · HEALTHCARE · BIOTECHNOLOGY

$6.01

+0.67% today

Updated 2026-04-29

Market cap

$1.47B

P/E ratio

—

P/S ratio

3.62x

EPS (TTM)

$-0.26

Dividend yield

—

52W range

$3 – $8

Volume

3.6M

Market cap

$1.47B

P/E ratio

—

P/S ratio

3.62x

EPS (TTM)

$-0.26

Dividend yield

—

52W range

$3 – $8

Volume

3.6M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

6.7

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

-1.0

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$16.44

+173.54%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy10 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $20.59M — positive

Risks

- Piotroski 3/9 — weak financial health

- Altman Z -1.04 — distress zone

- Thin margins at -15.10%

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$52.16M	$124.46M	$333.62M	$407.32M	$407.32M
Net income	$-67.21M	$-66.07M	$-39.14M	$-61.60M	$-407000.00
EPS	—	—	—	—	$-0.26
Free cash flow	$-70.10M	$-90.06M	$-45.82M	$-43.98M	$20.59M
Profit margin	-128.85%	-53.08%	-11.73%	-15.12%	-15.10%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ARDX	$1.47B	27	6.7	2.5	5.0	5.0	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Ardelyx Inc trades at $6.01. Our Smart Value Score of 27/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -1.04, it sits in the distress. TTM revenue stands at $407.32M. with profit margins at -15.10%.

Frequently asked questions

What is Ardelyx Inc's stock price?

Ardelyx Inc (ARDX) trades at $6.01.

Is Ardelyx Inc overvalued?

Smart Value Score 27/100 (Grade F, Strong Sell).

What is the price target of Ardelyx Inc (ARDX)?

The analyst target price is $16.44, representing +173.5% upside from the current price of $6.01.

What is Ardelyx Inc's revenue?

TTM revenue is $407.32M.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

-1.04 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.ardelyx.com

Quick metrics

P/S ratio3.62x

ROE-36.20%

Beta0.66

50D MA$6.04

200D MA$5.95

Shares out0.25B

Float0.22B

Short ratio—

Avg volume3.6M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ARDX vs LLY →ARDX vs JNJ →ARDX vs ABBV →Stock screener →